{"version":"1.0","provider_name":"IRLAB","provider_url":"https:\/\/irlab.se\/sv\/","title":"IRLAB meddelar positiva resultat fr\u00e5n studie med IRL790 - IRLAB","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"cSRiC9Enah\"><a href=\"https:\/\/irlab.se\/sv\/irlab-meddelar-positiva-resultat-fran-studie-med-irl790\/\">IRLAB meddelar positiva resultat fr\u00e5n studie med IRL790<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/irlab.se\/sv\/irlab-meddelar-positiva-resultat-fran-studie-med-irl790\/embed\/#?secret=cSRiC9Enah\" width=\"600\" height=\"338\" title=\"\u201dIRLAB meddelar positiva resultat fr\u00e5n studie med IRL790\u201d &ndash; IRLAB\" data-secret=\"cSRiC9Enah\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/irlab.se\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"IRLAB Therapeutics AB, listat p\u00e5 First North Premier, meddelar positiva resultat fr\u00e5n en kontrollerad studie som visar en tydlig minskning av ofrivilliga r\u00f6relser, s\u00e5 kallade dyskinesier, hos patienter med avancerad Parkinsons sjukdom behandlade med IRL790. Minskningen noterades med flera olika m\u00e4tmetoder. S\u00e5dana dyskinesier har hittills varit sv\u00e5ra att behandla och behovet av effektiva behandlingsformer \u00e4r stort. IRLAB Therapeutics inleder efter sommaren Fas II-studier, som \u00e4r fullt finansierade, avseende s\u00e5v\u00e4l IRL790 som bolagets andra prim\u00e4ra l\u00e4kemedelskandidat IRL752.\u00a0"}